Cargando…

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer

Proton boost of 20 Gy in daily 5 Gy fractions followed by external beam radiotherapy (EBRT) of 50 Gy in daily 2 Gy fractions were given to 278 patients with prostate cancer with T1b to T4N0M0 disease. Fifty-three percent of the patients received neoadjuvant androgen deprivation therapy (N-ADT). The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johansson, Silvia, Åström, Lennart, Sandin, Fredrik, Isacsson, Ulf, Montelius, Anders, Turesson, Ingela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399336/ https://www.ncbi.nlm.nih.gov/pubmed/22848840 http://dx.doi.org/10.1155/2012/654861

Ejemplares similares

Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas
por: Vlachogiannis, Pavlos, et al.
Publicado: (2017)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: patient reported quality of life outcomes
por: Morgan, Tiffany M, et al.
Publicado: (2018)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Is there a role for an external beam boost in cervical cancer radiotherapy?(†)
por: Sethi, Rajni A., et al.
Publicado: (2013)

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
por: Richardson, Matthew, et al.
Publicado: (2018)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

External beam radiotherapy for localized prostate cancer
por: Yilmaz, Hasan, et al.
Publicado: (2015)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
por: Oehler, Christoph, et al.
Publicado: (2022)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams
por: Benedek, Hunor, et al.
Publicado: (2018)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
por: Mahase, Sean, et al.
Publicado: (2020)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
por: Sabbagh, Ali, et al.
Publicado: (2023)

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis
por: Botrel, Tobias Engel Ayer, et al.
Publicado: (2013)

Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
por: Lee, Jeong Won, et al.
Publicado: (2022)

Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists
por: McClelland, Shearwood, et al.
Publicado: (2019)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer
por: Chu, William, et al.
Publicado: (2015)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study
por: Pettersson, Andreas, et al.
Publicado: (2020)

Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study
por: Martínez, Evelyn, et al.
Publicado: (2021)

FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification
por: Wei, Shouyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_efhm125oc0vtn8gog5fb5jbnn0